A team of scientists from Inönü and Adıyaman universities in Turkey has developed a Covid-19 antibody test kit. The enzyme-linked immunosorbent assay (ELISA)-based kit provides 95% accurate data on antibody levels after vaccination and will help in determining immunity levels in a community, Daily Sabah reports. The ELISA based kit has already qualified in the Health Ministry’s safety and accuracy tests and is ready for mass production.
The Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) in India has developed a reverse transcription polymerase chain reaction (RT-PCR) kit to facilitate detection of Covid-19. The kit is capable of providing results within two hours, reports The Hindu. The Indian Council of Medical Research (ICMR) validation shows that the kit has 97.3% sensitivity and 100% specificity in novel coronavirus detection. Huwel Lifesciences in Hyderabad has signed an agreement for the commercial supply of the kit.
DNANudge, which manufactures rapid Covid tests, has secured $60m funding in a round led by Ventura Capital. The funding will be used to scale up production and expand diagnostic applications, reports Bloomberg. The company will use the proceeds to produce cartridges for its portable devices that can detect Covid-19 in around an hour. DNANudge also makes cartridges for cancer testing and consumer skincare products.